/주식/SERA
SERA

SERA

USD

Sera Prognostics Inc. Class A Common Stock

$3.165-0.135 (-4.091%)

실시간 가격

Healthcare
의료 기기
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$3.300

고가

$3.355

저가

$3.145

거래량

0.02M

기업 기본 정보

시가총액

126.2M

산업

의료 기기

국가

United States

거래 통계

평균 거래량

0.11M

거래소

NGM

통화

USD

52주 범위

저가 $2.99현재가 $3.165고가 $12.355

AI 분석 리포트

마지막 업데이트: 2025년 4월 24일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

SERA (Sera Prognostics Inc. Class A Common Stock): Checking the Pulse After Recent Moves

Stock Symbol: SERA Generate Date: 2025-04-24 16:32:24

Let's break down what's been happening with Sera Prognostics stock lately, looking at the news, how the price has moved, and what some AI models are predicting. The goal here is to get a clear picture and think about what it might mean.

The Latest News Buzz

We saw news back on March 19th about Sera Prognostics reporting their financial results for the fourth quarter of 2024. Now, the title itself just says they reported, which is pretty standard stuff. However, other data points suggest the sentiment around recent news has actually been quite positive. This hints that maybe the results themselves, or perhaps other announcements around that time, were received well by the market. Good news can sometimes give a stock a lift, or at least stop it from falling further.

What the Price Chart Shows

Looking at the stock's journey over roughly the last three months, it's been a tough ride. Back in late January, shares were trading up around the $6.50 mark. From there, the price took a significant tumble through February and March, eventually hitting lows near $3.00 in early April. It's bounced around a bit since then, currently sitting around $3.37. So, the overall trend has been clearly downward for a while now.

Compared to that long slide, the current price is near the lower end of its recent range. The AI prediction for today and the next couple of days suggests a small upward nudge is expected – around 1% today, then potentially climbing over 3% in the following two days. This is interesting because it goes against the recent strong downtrend, hinting the AI sees a potential short-term turn or stabilization happening right about now.

Putting It All Together: What Might Be Next?

So, we have a stock that's been falling for months. Then, we hear that recent news sentiment was positive (even if we don't have the specifics of why it was positive from the earnings report title alone). On top of that, an AI model is predicting a small upward move starting right away.

Based on these pieces, the apparent near-term leaning is a bit mixed, but leans towards a potential short-term bounce or pause in the decline. The strong downtrend is the dominant historical pattern. However, the combination of reported positive news sentiment and the AI's prediction of immediate upward movement suggests there might be some underlying positive factors or technical signals the AI is picking up that could lead to a temporary reversal or stabilization.

If someone were considering this stock based on the AI's outlook and the positive sentiment signal, a potential entry consideration could be around the current price level ($3.37) or perhaps waiting to see if the AI's predicted bounce starts to materialize. The AI prediction starts from today's price, implying the current area is where it expects the move to begin.

For managing risk, setting a potential stop-loss is crucial, especially given the strong prior downtrend. A level below recent lows, maybe around $3.08 (which aligns with some analysis), could be a point to consider exiting if the price continues to fall instead of bouncing. On the flip side, if the AI prediction plays out and the price moves up, a potential take-profit level might be around $3.94, which could represent a reasonable gain from the current price and potentially hit some minor resistance points from earlier in the year.

A Little Company Context

It's worth remembering that Sera Prognostics is a healthcare company focused on developing tests for pregnancy-related conditions. This means their financial performance and stock price can be heavily influenced by clinical trial results, regulatory approvals, and market adoption of their tests. Also, it's a relatively small company with a modest market cap and sometimes lower trading volume, which can make the stock price more volatile.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

관련 뉴스

PR Newswire

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

더 보기
SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

AI 예측Beta

AI 추천

강세

업데이트 시간: 2025년 4월 27일 오후 11:10

약세중립강세

71.0% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
가치
트레이딩 가이드

진입점

$3.21

익절

$3.44

손절

$2.85

핵심 요소

DMI는 약세 추세(ADX:22.2, +DI:16.1, -DI:25.6)를 보여 주의를 요합니다.
현재 가격이 지지선($3.19)에 매우 근접하여 강력한 매수 기회를 시사합니다.
거래량은 평균(1,796)의 2.9배로 상당한 매수 관심을 보여줍니다.
MACD -0.0319이(가) 신호선 -0.0364 위에 있어 강세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기